Hot Hedge Fund Activity in Healthcare Stock Sector

Following is information on Perkins Investment Management’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011.

  • Thermo Fisher Scientific, Inc. (NYSE:TMO): On 6/30/11 Perkins Investment Management reported holding 2,523,160 shares with a market value of $162,466,271. This comprised 0.87% of the total portfolio. On 9/30/11, Perkins Investmnet Management held 2,751,204 shares with a market value of $139,320,969. This comprised 0.96% of the total portfolio. The net change in shares for this position over the two quarters is 228,044. About the company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Life Technologies Corporation (NASDAQ:LIFE): On 6/30/11 Perkins Investment Management reported holding 3,305,097 shares with a market value of $172,096,400. This comprised 0.92% of the total portfolio. On 9/30/11, Perkins Investmnet Management held 3,601,083 shares with a market value of $138,389,621. This comprised 0.95% of the total portfolio. The net change in shares for this position over the two quarters is 295,986. About the company: Life Technologies Corporation develops biotechnology tools used by researchers. The Company offers a broad range of products and services, including systems, instruments, reagents, and custom services. Life’s portfolio of products includes technologies for capillary electrophoresis based sequencing, sequencing, mass spectrometry sample preparation, and cell culture.
  • Steris Corp. (NYSE:STE): On 6/30/11 Perkins Investment Management reported holding 3,831,377 shares with a market value of $134,021,566. This comprised 0.72% of the total portfolio. On 9/30/11, Perkins Investmnet Management held 4,608,084 shares with a market value of $134,878,621. This comprised 0.93% of the total portfolio. The net change in shares for this position over the two quarters is 776,707. About the company: STERIS Corporation provides sterilization, microbial reduction, and materials modification services to customers throughout the world. The Company’s customers include the medical device, pharmaceutical, biotechnology, food safety, and industrial markets. STERIS also markets a line of cleaning, decontamination, and sterilization systems, products, and technologies.
  • Becton, Dickinson & Co. (NYSE:BDX): On 6/30/11 Perkins Investment Management reported holding 1,815,791 shares with a market value of $156,466,707. This comprised 0.84% of the total portfolio. On 9/30/11, Perkins Investmnet Management held 1,770,116 shares with a market value of $129,784,905. This comprised 0.89% of the total portfolio. The net change in shares for this position over the two quarters is -45,675. About the company: Becton, Dickinson and Company manufactures and sells a variety of medical supplies and devices and diagnostic systems. The Company’s products are used by health care professionals, medical research institutions, and the general public. Becton’s products are marketed worldwide.
  • Novartis AG (NYSE:NVS): On 6/30/11 Perkins Investment Management reported holding 2,240,790 shares with a market value of $136,934,678. This comprised 0.73% of the total portfolio. On 9/30/11, Perkins Investmnet Management held 2,258,312 shares with a market value of $125,946,061. This comprised 0.86% of the total portfolio. The net change in shares for this position over the two quarters is 17,522. About the company: Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases; oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis; vaccines and diagnostics; vision, and animal health products.
  • Charles River Laboratories International, Inc. (NYSE:CRL): On 6/30/11 Perkins Investment Management reported holding 2,642,948 shares with a market value of $107,435,840. This comprised 0.57% of the total portfolio. On 9/30/11, Perkins Investmnet Management held 3,896,954 shares with a market value of $111,530,827. This comprised 0.77% of the total portfolio. The net change in shares for this position over the two quarters is 1,254,006. About the company: Charles River Laboratories International, Inc. provides research tools and support services that enable drug discovery and development. The Company provides the animal research models required in research and development for new drugs, devices, and therapies. Charles River’s customers include pharmaceutical and biotechnology companies, hospitals, and academic institutions.
  • Hologic, Inc. (NASDAQ:HOLX): On 6/30/11 Perkins Investment Management reported holding 4,996,648 shares with a market value of $100,782,391. This comprised 0.54% of the total portfolio. On 9/30/11, Perkins Investmnet Management held 6,637,489 shares with a market value of $100,956,208. This comprised 0.69% of the total portfolio. The net change in shares for this position over the two quarters is 1,640,841. About the company: Hologic, Inc. develops, manufactures, and markets x-ray systems. The Company makes x-ray bone densitometers that measure the precise bone density for use in the diagnosing of metabolic bone diseases such as osteoporosis.
  • Laboratory Corp. of America Holdings (NYSE:LH): On 6/30/11 Perkins Investment Management reported holding 1,229,873 shares with a market value of $119,039,409. This comprised 0.64% of the total portfolio. On 9/30/11, Perkins Investmnet Management held 1,209,808 shares with a market value of $95,635,326. This comprised 0.66% of the total portfolio. The net change in shares for this position over the two quarters is -20,065. About the company: Laboratory Corporation of America Holdings is a clinical laboratory organization. The Company offers a wide range of clinical laboratory tests which are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. Laboratory Corporation operates a network of laboratories and service sites which serve clients across the United States.
  • Zimmer Holdings, Inc. (NYSE:ZMH): On 6/30/11 Perkins Investment Management reported holding 2,138,263 shares with a market value of $135,138,223. This comprised 0.72% of the total portfolio. On 9/30/11, Perkins Investmnet Management held 1,675,980 shares with a market value of $89,631,410. This comprised 0.61% of the total portfolio. The net change in shares for this position over the two quarters is -462,283. About the company: Zimmer Holdings, Inc. designs, develops, manufactures, and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services. Zimmer markets its products in the United States and other countries around the world.
  • Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA): On 6/30/11 Perkins Investment Management reported holding 2,473,454 shares with a market value of $119,269,955. This comprised 0.64% of the total portfolio. On 9/30/11, Perkins Investmnet Management held 2,299,430 shares with a market value of $85,584,787. This comprised 0.59% of the total portfolio. The net change in shares for this position over the two quarters is -174,024. About the company: Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.

(Note: Data regarding Perkins Investment Management’s stock holdings are sourced from whalewisdom.com.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

Check out our analysis of Jim Cramer’s latest stock calls

More from The Cheat Sheet